Single Injection may provide weeks of glucose control in Diabetes Ruby khatun khatun6 Jun 2017 3:18 PM ISTBiomedical engineers at Duke University have created a technology that might provide weeks of glucose control for diabetes with a single injection,...
Breakthrough treatment for nonalcoholic fatty liver disease Dr. Kamal Kant Kohli Kohli6 Dec 2017 7:28 PM ISTLately improved understanding of the mechanisms behind NAFLD has led to new approaches to pharmacotherapy. This review presents an overview of current...
New diabetes drug That reduces Blood sugar as well as weight : Lancet Medha Baranwal Baranwal30 Jun 2018 8:28 PM ISTIn obese or overweight patients with type diabetes (T2D), treatment with MEDI0382, a balanced glucagon-like peptide-1 and glucagon receptor dual...
Semaglutide manages diabetes and weight better than other GLP-1 receptor agonists Medha Baranwal Baranwal18 Aug 2018 8:10 PM ISTSwitching to semaglutide, a GLP-1 analog, from another GLP-1 receptor agonists (such as liraglutide, dulaglutide or exenatide) resulted in a further...
Diabetes medications linked to increased risk of amputation Medha Baranwal Baranwal19 Nov 2018 7:28 PM ISTType 2 diabetes (T2D) patients treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors have an increased risk of lower-limb amputation and...
Study identifies diabetes drugs that are effective in diabetic retinopathy Medha Baranwal Baranwal29 July 2019 7:30 PM ISTSydney, Australia: A recent review published in the journal Eye has thrown light on the non-insulin anti-hyperglycemic agents used for the treatment...
Liraglutide addition to Insulin leads to better perioperative blood sugar control in diabetes Medha Baranwal Baranwal5 Aug 2019 8:28 PM ISTGlucagon-like peptide-1 (GLP-1) receptor agonists like liragutide lead to better perioperative blood sugar control in diabetes when added to insulin...
Type 2 diabetes: Oral Semaglutide does not increase CVD risk Medha Baranwal Baranwal17 Sept 2019 8:55 AM ISTCanada: Oral semaglutide does not increase cardiovascular risk in patients with type 2 diabetes, according to a recent study published in The New...
GLP-1 levels may predict cardiovascular risk in heart attack Medha Baranwal Baranwal3 Nov 2019 8:20 PM ISTGermany: The levels of glucagon-like peptide 1 (GLP-1) can predict cardiovascular risk in patients with acute myocardial infarction (heart attack),...
ADA releases 2019 Standards of Medical Care in Diabetes Dr. Kamal Kant Kohli Kohli19 Dec 2018 7:00 PM ISTThe American Diabetes Association has released its revised clinical practice recommendations 2019 Standards of Medical Care in Diabetes , which will...
